Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study
Clinical trial NCT07008508 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07008508
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-15
- Primary completion
- 2032-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.